These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis. Tzartos SJ; Morel E; Efthimiadis A; Bustarret AF; D'Anglejan J; Drosos AA; Moutsopoulos HA Clin Exp Immunol; 1988 Oct; 74(1):80-6. PubMed ID: 2464451 [TBL] [Abstract][Full Text] [Related]
70. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis]. Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698 [TBL] [Abstract][Full Text] [Related]
71. D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis. Ciompi ML; Marchetti G; Bazzichi L; Puccetti L; Agelli M Rheumatol Int; 1995; 15(3):95-7. PubMed ID: 8588126 [TBL] [Abstract][Full Text] [Related]
79. Role of penicillamine for the induction of myasthenia gravis. Smith CI; Hammarström L; Matell G; Nilsson BY Eur Neurol; 1983; 22(4):272-82. PubMed ID: 6884397 [TBL] [Abstract][Full Text] [Related]
80. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment]. Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]